Biliary Tract Cancer - 80 Studies Found
| Completed |
: A Phase I Study of Adjuvant Chemotherapy With GC in Biliary Tract Cancer Undergoing Resection Without Major Hepatectomy : Biliary Tract Cancer : 2011-02-07 : Drug: gemcitabine , cisplatin Dose of gemcitabine and cisplatin and treatment schedule |
| Recruiting |
: A Phase II Trial of Preoperative Chemotherapy for Biliary Tract Cancer (BTC) With Node Metastasis : Biliary Tract Cancer : 2013-03-22 : Drug: Gemcitabine, Cisplatin, S-1 Preoperative chemotherap |
| Not yet recruiting |
: Study of Pembrolizumab in Metastatic Biliary Tract Cancer as Second-line Treatment After Failing to at Least One Cytotoxic Chemotherapy Regimen: Integration of Genomic Analysis to Identify Predictive Molecular Subtypes : Biliary Tract Cancer : 2017-03-16 : Drug: MK3475 anti-PD1 immunotherapy Other Name: Pemb |
| Active, not recruiting |
: A Study of S-1 in Combination With Gemcitabine as First-Line Treatment in Patients With Advanced Biliary Tract Cancer : Advanced Biliary Tract Cancer(BTC) : 2015-03-26 : Drug: S-1/Gemcitabine Eligible patients will receive gemcitabine 800 mg/m2/day on day 1 and S-1 orally 8 |
| Active, not recruiting |
: Study of TH-302 Monotherapy as Second-line Treatment in Advanced Biliary Tract Cancer : Biliary Tract Cancer : 2015-04-26 : Drug: TH-302 monotherapy TH-302 (480 ) mg/m2 D1, D8, D15 Q 4 weeks |
| Not yet recruiting |
: Study of Varlitinib Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer : Advanced or Metastatic Biliary Tract Cancer : 2017-04-21 :
|
| Recruiting |
: Gemcitabine, Cisplatin, and Abraxane in Advanced Biliary Cancers : Biliary Tract Cancer : 2015-03-13 :
|
| Recruiting |
: GAMBIT Trial: Cisplatin Plus Irinotecan in the Treatment of Gallbladder or Biliary Tract Cancer : Biliary Cancer : 2013-05-14 :
|
| Terminated |
: Randomized Trial of Gemcitabine/Cisplatin Versus S-1/Cisplatin in Advanced Biliary Cancer :
|
| Completed |
: Salvage mFOLFOX in BTC After Failure of Gemcitabine : Unresectable Biliary Tract Cancer : 2010-05-05 : Drug: 5-fluorouracil, leucovorin, oxaliplatin D1 Oxaliplatin 85mg/m2 D1, 2 LV 30mg/m2 IV push D1, 2 5-FU |